Astrana Health (ASTH) Non-Current Deffered Revenue (2015 - 2017)

Astrana Health has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $683504.0 for Q3 2017.

• Non-Current Deffered Revenue for Q3 2017 came in at $683504.0, down 16.58% year-over-year; the trailing twelve-month figure through Sep 2017 was $683504.0 (down 16.58% YoY), and the FY2017 annual result was $747418.0, up 2.54% from the prior year.
• Non-Current Deffered Revenue came in at $683504.0 for Q3 2017 at Astrana Health, down from $715462.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $819375.0 in Q3 2016 to a low of $11610.0 in Q1 2015.
• The 3-year median for Non-Current Deffered Revenue is $728877.0 (2016), against an average of $661450.6.
• Across the five-year window, Non-Current Deffered Revenue soared 6178.01% in 2016 and retreated 16.58% in 2017, its largest moves.
• Astrana Health's Non-Current Deffered Revenue stood at $670000.0 in 2015, then grew by 21.54% to $814348.0 in 2016, then decreased by 16.07% to $683504.0 in 2017.
• The last three Non-Current Deffered Revenue figures came in at $683504.0 (Q3 2017), $715462.0 (Q2 2017), and $747418.0 (Q1 2017), per Business Quant data.